Comparison of Percutaneous Coronary Intervention (With Drug-Eluting Stents) Versus Coronary Artery Bypass Grafting in Women With Severe Narrowing of the.

Slides:

Advertisements

Similar presentations

Usefulness of Platelet Response to Clopidogrel by Point-of-Care Testing to Predict Bleeding Outcomes in Patients Undergoing Percutaneous Coronary Intervention.

Advertisements

Date of download: 7/8/2016 Copyright © The American College of Cardiology. All rights reserved. From: Fractional Flow Reserve Versus Angiography for Guiding.

Cost Savings Associated With Implementation of Peer-Reviewed Appropriate Use Criteria for Percutaneous Coronary Interventions Pranav Puri, Jennifer Carroll,

Outcomes of a Pharmacoinvasive Strategy for Successful Versus Failed Fibrinolysis and Primary Percutaneous Intervention in Acute Myocardial Infarction.

Pulmonary artery catheterization in acute coronary syndromes: Insights from the GUSTO IIb and GUSTO III trials Mauricio G. Cohen, MD, Robert V. Kelly,

Rationale and design of the Fractional Flow Reserve versus Angiography for Multivessel Evaluation (FAME) 3 Trial: A comparison of fractional flow reserve–guided.

Trends in Outcomes of Revascularization for Left Main Coronary Disease or Three- Vessel Disease With the Routine Incorporation of Fractional Flow Reserve.

Usefulness of Preprocedure High-Sensitivity C-Reactive Protein to Predict Death, Recurrent Myocardial Infarction, and Stent Thrombosis According to Stent.

The “occasional open heart surgeon” revisited

Figure 1 A flow chart describing the systematic process followed for article selection. From: A systematic review of cost-effectiveness of percutaneous.

Previous coronary stents do not increase early and long-term adverse outcomes in patients undergoing off-pump coronary artery bypass grafting: A propensity-matched.

Meta-Analysis of Three Randomized Trials and Nine Observational Studies Comparing Drug-Eluting Stents Versus Coronary Artery Bypass Grafting for Unprotected.

Frequency of Percutaneous Coronary Interventions at Facilities Without On-Site Cardiac Surgical Backup—A Report from the American College of Cardiology–National.

Meta-Analysis of Dietary Glycemic Load and Glycemic Index in Relation to Risk of Coronary Heart Disease Jia-Yi Dong, BSc, Yong-Hong Zhang, MD, PhD, Peiyu.

Comparison of Bare-Metal Stents and Drug-Eluting Stents in Coronary Ostial Lesions (from the National Heart, Lung, and Blood Institute Dynamic Registry)

Influence of Body Mass Index on Long-Term Survival After Cardiac Catheterization Barak Zafrir, MD, Ronen Jaffe, MD, Ronen Rubinshtein, MD, Basheer Karkabi,

Alfred A. Bartolucci, PhD, Michal Tendera, MD, George Howard, DrPH

Two-Year Clinical Outcomes After Enhanced External Counterpulsation (EECP) Therapy in Patients With Refractory Angina Pectoris and Left Ventricular Dysfunction.

Multiple arterial grafts improve survival with coronary artery bypass graft surgery versus conventional coronary artery bypass grafting compared with.

Percutaneous coronary invervention versus coronary artery bypass grafting: A meta- analysis Yolba Smit, MD, MSc, Joan Vlayen, MD, Hetty Koppenaal, MD,

Repeated Target Vessel Revascularization After Coronary Artery Bypass for In-Stent Restenosis Jung-Hwan Kim, MD, Seung Hyun Lee, MD, PhD, Hyun-Chel Joo,

Development of Clinical Practice Guidelines in the Care of People With Kidney Disease: Core Curriculum 2016 Angela C. Webster, PhD, Evi V. Nagler, MD,

Cyrus J. Parsa, MD, Linda K. Shaw, MS, J. Scott Rankin, MD, Mani A

Early Invasive Versus Initial Conservative Strategies for Women with Non–ST-Elevation Acute Coronary Syndromes: A Nationwide Analysis Islam Y. Elgendy,

Impact of 64-Slice Multidetector Computed Tomography on Other Diagnostic Studies for Coronary Artery Disease Alex J. Auseon, DO, Sunil S. Advani, MD,

Jeevan Nagendran, MD, Colleen M. Norris, PhD, Michelle M

Bypass Versus Drug-Eluting Stents at Three Years in SYNTAX Patients With Diabetes Mellitus or Metabolic Syndrome Michael J. Mack, MD, Adrian P. Banning,

The Value of Percutaneous Coronary Intervention in Aortic Valve Stenosis with Coronary Artery Disease Ronny Alcalai, MD, Nicola Viola, MD, Morris Mosseri,

Pulmonary artery catheterization in acute coronary syndromes: Insights from the GUSTO IIb and GUSTO III trials Mauricio G. Cohen, MD, Robert V. Kelly,

Equivalency of Saphenous Vein and Arterial Composite Grafts: 5-Year Angiography and Midterm Clinical Follow-Up Ho Young Hwang, MD, PhD, Kyung-Hak Lee,

2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease Glenn N. Levine, MD, FACC, FAHA,

Stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: A meta-analysis of comparative studies Hisato Takagi,

Unprotected Left Main Coronary Artery Stenting Versus Coronary Artery Bypass Graft Surgery Hisato Takagi, MD, PhD, Hideaki Manabe, MD, Norikazu Kawai,

Peter K. Smith, MD The Journal of Thoracic and Cardiovascular Surgery

The impact of a second arterial graft on 5-year outcomes after coronary artery bypass grafting in the Synergy Between Percutaneous Coronary Intervention.

Latin American randomized trial of balloon angioplasty vs coronary stenting for small vessels (LASMAL): Immediate and long-term results Alfredo Rodriguez,

Peter K. Smith, MD The Annals of Thoracic Surgery

J. Trevor Posenau, MD, Daniel M. Wojdyla, MS, Linda K

Effect of PCI on 1-year risk of all-cause mortality and major cardiovascular outcomes. CABG, coronary artery bypass grafting; CI, confidence interval (bars);

Characteristics of Contemporary Patients Discharged From the Hospital After an Acute Coronary Syndrome Robert J. Goldberg, PhD, Jane S. Saczynski, PhD,

Coronary artery bypass grafting is superior to first-generation drug-eluting stents for unprotected left main coronary artery disease: An updated meta-analysis.

Defining operative mortality: Impact on outcome reporting

Why surgery won the SYNTAX trial and why it matters

Zhe Zheng, MD, PhD, Heng Zhang, MD, PhD, Bo Xu, MBBS

Coronary Artery Disease in Women: Shyly Bold?

Early and long-term outcomes of coronary artery bypass grafting in patients with acute coronary syndrome versus stable angina pectoris Toshihiro Fukui,

Off-pump versus on-pump coronary artery bypass grafting: Insights from the Arterial Revascularization Trial Umberto Benedetto, MD, PhD, Douglas G. Altman,

Minimally invasive direct coronary artery bypass improves late survival compared with drug-eluting stents in isolated proximal left anterior descending.

Hisato Takagi, MD, PhD, Hideaki Manabe, MD, Takuya Umemoto, MD, PhD

The effect of coronary artery bypass grafting on specific causes of long-term mortality in the Bypass Angioplasty Revascularization Investigation David.

Recent Temporal Changes in Atherosclerotic Cardiovascular Diseases in Ontario: Clinical and Health Systems Impact Jack V. Tu, MD, PhD, Anam M. Khan,

Impact of drug-eluting stent selection on long-term clinical outcomes in patients treated for unprotected left main coronary artery disease: The sirolimus.

Do the EXCEL and NOBLE Trial Results Change Meta-Analysis Findings?

Complete Revascularization of the Three-Vessel Territories Using a Left Internal Thoracic Artery Composite Graft Ho Young Hwang, MD, PhD, Hong Chul Oh,

For everything there is a season

Survival probability loss from percutaneous coronary intervention compared with coronary artery bypass grafting across age groups Umberto Benedetto,

To bypass or stent? The changing rules of an advancing game

Drug-eluting stents versus coronary artery bypass grafting for the treatment of coronary artery disease: A meta-analysis of randomized and nonrandomized.

One-year outcomes of coronary artery bypass graft surgery versus percutaneous coronary intervention with multiple stenting for multisystem disease: A.

Chronic obstructive pulmonary disease severity influences outcomes after off-pump coronary artery bypass Benjamin Medalion, MD, Michael G. Katz, MD,

Stent Versus Off-Pump Coronary Bypass Grafting in the Second-Generation Drug- Eluting Stent Era Gijong Yi, MD, PhD, Hyun-Chel Joo, MD, Young-Nam Youn,

Glenn N. Levine et al. JACC 2011;58:e44-e122

Figures showing the effects of a potential 30% relative reduction in events with next-generation drug-eluting stents in the percutaneous coronary intervention.

Comparison of 30-day outcomes of coronary artery bypass grafting surgery verus hybrid coronary revascularization stratified by SYNTAX and euroSCORE Marzia.

Davide Capodanno et al. JCIN 2009;2:

Effect of PCI on 3 to 5-year risk of all-cause mortality and major cardiovascular outcomes. CABG, coronary artery bypass grafting; CI, confidence interval.

Improved Long-Term Survival for Diabetic Patients With Surgical Versus Interventional Revascularization Paul Kurlansky, MD, Morley Herbert, PhD, Syma.

The Clinical Significance and Management Implications of Chronic Total Occlusion Associated With Surgical Coronary Artery Revascularization Lorenzo Azzalini,

Utilization and Outcomes of Unprotected Left Main Coronary Artery Stenting and Coronary Artery Bypass Graft Surgery Chuntao Wu, MD, PhD, Edward L. Hannan,

Revascularization in severe ventricular dysfunction (15% ≤ LVEF ≤ 30%): a comparison of bypass grafting and percutaneous intervention Koichi Toda, MD,

Presentation transcript:

Comparison of Percutaneous Coronary Intervention (With Drug-Eluting Stents) Versus Coronary Artery Bypass Grafting in Women With Severe Narrowing of the Left Main Coronary Artery (from the Women–Drug-Eluting stent for LefT main coronary Artery disease Registry) Gill Louise Buchanan, MBChB, Alaide Chieffo, MD, Emanuele Meliga, MD, Roxana Mehran, MD, Seung-Jung Park, MD, Yoshinobu Onuma, MD, Piera Capranzano, MD, Marco Valgimigli, MD, Inga Narbute, MD, Raj R. Makkar, MD, Igor F. Palacios, MD, Young-Hak Kim, MD, Piotr P. Buszman, MD, Tarun Chakravarty, MD, Imad Sheiban, MD, Christoph Naber, MD, Ronan Margey, MD, Arvind Agnihotri, MD, Sebastiano Marra, MD, Davide Capodanno, MD, PhD, Victoria Allgar, BSc (Hons), PhD, Martin B. Leon, MD, Jeffrey W. Moses, MD, Jean Fajadet, MD, Thierry Lefevre, MD, Marie-Claude Morice, MD, Andrejs Erglis, MD, Corrado Tamburino, MD, PhD, Ottavio Alfieri, MD, Patrick W. Serruys, MD, Antonio Colombo, MD American Journal of Cardiology Volume 113, Issue 8, Pages 1348-1355 (April 2014) DOI: 10.1016/j.amjcard.2014.01.409 Copyright © 2014 Elsevier Inc. Terms and Conditions

Figure 1 Freedom from cardiac and cerebrovascular events in PCI versus CABG in the overall population. Freedom from death, MI, and CVAs (A); from death and MI (B); from death (C); and from MACCEs (D) after PCI (blue line) versus CABG (green line) in the overall population. Patients at risk at different times are reported below each graph. American Journal of Cardiology 2014 113, 1348-1355DOI: (10.1016/j.amjcard.2014.01.409) Copyright © 2014 Elsevier Inc. Terms and Conditions

Figure 2 Freedom from cardiac and cerebrovascular events in PCI versus CABG in the propensity score–matched groups. Freedom from cardiac death, MI, and CVAs (A); from death and MI (B); from death (C); and from MACCEs (D) after PCI (blue line) versus CABG (green line) in the propensity score–matched groups. Patients at risk at different times are reported below each graph. American Journal of Cardiology 2014 113, 1348-1355DOI: (10.1016/j.amjcard.2014.01.409) Copyright © 2014 Elsevier Inc. Terms and Conditions